Sechenov School
Home › Microbiology › Nontuberculous Mycobacteria

Nontuberculous Mycobacteria

Mycobacterium (nontuberculous group)

For medical students2 min readUpdated 2026-10-10

Nontuberculous mycobacteria (NTM) are a large group of opportunistic microorganisms that inhabit the environment as saprophytes. Unlike the true tuberculosis pathogen, they are not transmitted from person to person, but they can cause severe infections (mycobacterioses) in immunocompromised individuals.

SynonymsAlso referred to in literature as atypical or opportunistic mycobacteria.
EpidemiologyAn infected person is not contagious to others (representing an 'epidemiologic dead end').
TherapyThey exhibit marked natural resistance to standard antituberculous drugs.
Target OrgansThey most frequently affect the respiratory system (lungs), and less commonly the skin, lymph nodes, and genitourinary tract.

Biological Properties, Epidemiology, and Pathogenesis

Nontuberculous mycobacteria belong to the genus Mycobacterium. In their basic biological characteristics, they closely resemble classic tuberculosis pathogens, yet they possess several crucial clinical and epidemiological differences. First, they exhibit intrinsic multidrug resistance. Second, infection is virtually incapable of spreading from a sick person to a healthy one.

In their natural environment, these bacteria are typical saprophytes. Their reservoir is broad: they freely inhabit soil, water, and household dust. Moreover, certain species (e.g., M. smegmatis) can be part of the normal human microflora.

Transmission occurs via three main routes:

Upon entering the body, NTM cause mycobacterioses—diseases whose clinical presentation closely mimics tuberculosis. Specific granulomas form in the affected tissues. The primary risk factor triggering the pathology is the presence of immunodeficiency states, including those induced by immunosuppressive therapy.

Runyon Classification

In practical microbiology, the Runyon classification is used to systematize NTM. It divides all atypical mycobacteria into four major groups based on colony growth rate on artificial media, pigment production relative to exposure to light, as well as morphological and biochemical properties.

GroupPigmentation CharacteristicsGrowth RateTypical Representatives
1. PhotochromogensForm a yellow-orange (carotene) pigment exclusively upon light exposure.Slow-growingM. kansasii, M. marinum
2. ScotochromogensSynthesize yellow pigment in the dark. Exposure to light intensifies the color to orange-red.Slow-growingM. scrofulaceum, M. gordonae
3. NonchromogensPigment is entirely absent; colonies remain colorless under any conditions.Slow-growingM. avium complex
4. Rapid growersMay possess properties of photo- or scotochromogens.Rapid growth (from 1–2 to 7 days)M. fortuitum, M. smegmatis, M. chelonei

Microbiological Diagnostics Algorithm

The diagnosis of mycobacterioses follows algorithms similar to those for tuberculosis detection, though laboratories face specific differential challenges. The key and most informative method is bacteriological (culture) isolation.

Working with the isolated pure culture involves two major stages:

  1. Differentiation: specialists must precisely determine whether the isolate is a true tuberculosis pathogen or a nontuberculous mycobacterium.
  2. Identification: once NTM presence is confirmed, the specific species must be determined, its virulence assessed, and its Runyon group established.

Identification involves several levels. Basic tuberculosis dispensary laboratories perform initial evaluations: analyzing colony growth rate, morphology, pigment production, and temperature preferences. Final verification is carried out exclusively in specialized reference laboratories, where biochemical tests and bioassays (inoculation of laboratory animals such as rats, mice, or chicks) are performed. Drug susceptibility testing of the culture is mandatory.

Auxiliary methods include smear microscopy and serological tests (antibody detection). Skin-allergy tests hold little diagnostic value in mycobacterioses.

Principles of Treatment and Prevention

Treating mycobacterioses is a complex task because NTM exhibit intrinsic multidrug resistance (MDR). Standard antituberculous regimens are frequently ineffective. As drugs of choice, clinicians use agents to which the microorganisms retain susceptibility—for example, cycloserine, ethambutol, and rifampin.

Specific prophylaxis for mycobacterioses has not been developed to date, and effective vaccines are lacking.

Mnemonic

To easily remember the Runyon groups, pay attention to the word roots: PHOTOchromogens require light to synthesize pigment, SCOTOchromogens (from Greek skotos — darkness) do not require light, NONchromogens always remain pale, and the fourth group is distinguished exclusively by its rapid growth rate.

Frequently asked questions

Which specific biochemical tests are used to differentiate nontuberculous mycobacteria from M. tuberculosis?

The referenced sources indicate that biochemical tests are used during the final identification stage of nontuberculous mycobacteria, but a specific battery of tests for differentiating NTM from M. tuberculosis is not listed. The niacin test characterizes the ability of M. tuberculosis to synthesize large amounts of niacin. Nitrate reductase and pyrazinamidase tests are mentioned in the source for differentiating M. tuberculosis and M. bovis, rather than nontuberculous mycobacteria.

Which groups of antibacterial drugs are used to treat mycobacterioses?

The sources list the following drugs and groups for treating mycobacterioses: macrolides (azithromycin, clarithromycin); aminoglycoside (amikacin); as well as rifampin, ethambutol, cycloserine, tigecycline, imipenem-cilastatin, cefoxitin, minocycline, moxifloxacin, and linezolid. For MAC therapy, a combination of a macrolide, rifampin, and ethambutol is indicated. Drug selection is guided by drug susceptibility test results. Therapy may be ineffective due to the intrinsic multidrug resistance of NTM.

What risk factors, aside from immunodeficiency, contribute to the development of mycobacterioses?

In addition to immunodeficiency states, the development of mycobacterioses is associated with the use of immunosuppressants.

How do mycobacterioses fundamentally differ from tuberculosis in terms of epidemiology?

The main difference is the lack of contagiousness. Nontuberculous mycobacteria are acquired from the external environment, and transmission of the pathogen from a sick person to a healthy one does not occur.

Why do standard antituberculous regimens fail in the treatment of mycobacterioses?

Atypical mycobacteria possess marked intrinsic resistance to many primary antituberculous drugs, requiring individualized antibiotic selection (e.g., cycloserine or rifampin).

What is the primary diagnostic method for mycobacterioses?

The primary method is bacteriological (culture) isolation. It allows not only the isolation of the pathogen but also the determination of its species, Runyon group, and antibiotic susceptibility.

Go deeper

More topics in Microbiology

Bacterial Gene Transfer MechanismsClusters of Differentiation (CD Markers): Anatomy and FunctionProbiotics: Mechanisms, Indications and Clinical ApplicationComplement-Mediated Serological ReactionsEnterococciCoxiella burnetii: Causative Agent of Q FeverClostridium botulinumProteusRelapsing FeversChlamydophila pneumoniae: Pathogen of Respiratory ChlamydiosisPathogenesis and Clinical Features of InfluenzaRespiratory Syncytial VirusMicrobiology →